← Back to Search

arm 1 for Glycemic Responses (GLIN#3 Trial)

N/A
Recruiting
Research Sponsored by Nutricia Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 and ≤ 65 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

GLIN#3 Trial Summary

This trial is trying to understand how different foods affect blood sugar levels. Participants will come to the study visit on an empty stomach and will be given either a regular food or a special food to eat.

Who is the study for?
This trial is for individuals who are interested in how different nutritional products affect blood sugar levels. Participants will need to fast before consuming the test product and provide blood samples over a two-hour period.Check my eligibility
What is being tested?
The study is testing various 'concept' and 'reference' nutritional products to see how they influence glycemic responses. Subjects will consume one serving of either a reference or test product, followed by regular blood sampling.See study design
What are the potential side effects?
Since this trial involves consumption of nutritional products, side effects may include digestive discomfort or allergic reactions if participants have sensitivities to ingredients in the products.

GLIN#3 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

GLIN#3 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The glycemic index of nutritional products
Secondary outcome measures
1. The postprandial glucose levels at each time point after each test product compared with the mean of the 3 references
2. The postprandial incremental area under the curve (iAUC) after each test product compared with the mean of the 3 references

GLIN#3 Trial Design

18Treatment groups
Experimental Treatment
Group I: arm 9Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group II: arm 8Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group III: arm 7Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group IV: arm 6Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group V: arm 5Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group VI: arm 4Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group VII: arm 3Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group VIII: arm 2Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group IX: arm 18Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group X: arm 17Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XI: arm 16Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XII: arm 15Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XIII: arm 14Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XIV: arm 13Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XV: arm 12Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XVI: arm 11Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XVII: arm 10Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.
Group XVIII: arm 1Experimental Treatment1 Intervention
All subjects will receive all interventions during the trial. The order of the Nutritional products will be randomized.

Find a Location

Who is running the clinical trial?

Nutricia ResearchLead Sponsor
45 Previous Clinical Trials
6,382 Total Patients Enrolled
2 Trials studying Glycemic Responses
25 Patients Enrolled for Glycemic Responses

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be a participant in this clinical trial?

"To be eligible for this research study, potential participants must demonstrate glycemic responses within the age range of 18 to 65. The aim is to recruit a total of 12 individuals for this investigation."

Answered by AI

Are participants being enrolled in this study at the present time?

"According to the information available on clinicaltrials.gov, this particular clinical trial is not currently recruiting participants. It was initially posted on January 24th, 2024, and last edited on January 10th, 2024. However, it's worth noting that there are three other ongoing trials actively seeking eligible patients at present."

Answered by AI

Does this research project include the participation of individuals who are above the age of 80?

"To be eligible for participation in this study, individuals must meet the age requirements of being at least 18 years old and not exceeding 65 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Glin3: Assessment of the Glycemic Responses to Nutritional Products
2024. "Glin3: Assessment of the Glycemic Responses to Nutritional Products". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06215534.
~3 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top